Jeffrey A. Schwaneke - 10 Jan 2026 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Financial Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
10 Jan 2026
Net transactions value
$0
Form type
4
Filing time
13 Jan 2026, 16:44:56 UTC
Previous filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schwaneke Jeffrey A. Chief Financial Officer C/O AGILON HEALTH, INC., 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE /s/ Mimi Yang, as Attorney-in-Fact 13 Jan 2026 0001446919

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +600,000 +56% $0.000000 1,675,122 10 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in three equal installments on each anniversary of January 10, 2026.
F2 Includes restricted stock units.